Tyler Shultz is a prominent American researcher, entrepreneur, and whistleblower known for his significant contributions to healthcare diagnostics and ethical entrepreneurship. In 2017, he co-founded Flux Biosciences, a biotechnology company dedicated to developing innovative healthcare diagnostics for household use. Under his leadership as CEO, Flux has focused on addressing women’s fertility issues through advanced in-vitro diagnostics, showcasing Shultz’s commitment to improving health outcomes through accessible technology.

Shultz gained national recognition as a whistleblower during the Theranos scandal, where he played a pivotal role in exposing the company’s fraudulent practices. Initially hired as an intern in 2013, he quickly rose to a research engineer position, working on the controversial Edison device. After uncovering serious internal malpractice and data manipulation, Shultz courageously reported his findings to The Wall Street Journal, becoming a key source for investigative journalist John Carreyrou. His actions not only contributed to the downfall of Theranos but also highlighted the importance of integrity in the biotech industry.

In 2017, Shultz was honored in Forbes’ 30 Under 30 for Healthcare, recognized for shaping one of the year’s most significant healthcare stories. He also received the James Madison Freedom of Information Award for his bravery in whistleblowing. Beyond his entrepreneurial ventures, he has been actively involved in advising Ethics in Entrepreneurship, a nonprofit organization aimed at fostering ethical practices in business.

In 2022, Shultz founded The Healthyr Company, which focuses on providing health insights through blood sample analysis. His ongoing commitment to ethical entrepreneurship and healthcare innovation continues to inspire many in the industry, as he advocates for transparency and accountability in biotechnology.